miR-107 promoted GC cell proliferation and metastasis by targeting FOXO1, a transcription factor downstream of AKT signaling, and FAT4, a tumor suppressor suppressing PI3K/AKT signaling113,114. This evidence concerns the gene AKT1 and gastric cancer.